147 Tetanus

Question 1

Maternal tetanus is defined as tetanus occurring during pregnancy or up to how long after pregnancy? (H20 C147 P1102)

Answer 1

6 weeks

Question 2

Most common infection sites of tetanus in adults (H20 C147 P1102)

Answer 2

Superficial abrasions to the limbs

Question 3

Persons of this age are at greatest risk of tetanus (H20 C147 P1102)

Answer 3

> 60 years

Question 4

Tetanospasmin light chains cleaves this protein (H20 C147 P1103)

Answer 4

Synaptobrevin

Question 5

Time from wound to first symptom of tetanus (H20 C147 P1103)

Answer 5

Incubation period

Question 6

Time from first symptom to first generalized spasm in tetanus (H20 C147 P1103-4)

Answer 6

Period of onset

Question 7

Most common cause of death in tetanus (H20 C147 P1104)

Answer 7

Respiratory failure

Question 8

Major risk during the second week of severe tetanus (H20 C147 P1104)

Answer 8

Death due to cardiovascular events

Question 9

Serum anti-tetanus IgG levels that are deemed supportive and do not support the diagnosis of tetanus (H20 C147 P1104)

Answer 9

> 0.1 IU/mL

Question 10

Character of abdominal pain in teranus that differentiates it from strychnine poisoning and dystonic reaction to antidopaminergic drugs (H20 C147 P1104)

Answer 10

Continuous

Question 11

Preferred antibiotic therapy for tetanus (H20 C147 P1104)

Answer 11

Metronidazole

Question 12

Dose of human TIG for treatment of tetanus (H20 C147 P1104)

Answer 12

3000-5000 IU

Question 13

Dose of equine-derived TIG in the treatment of tetanus (H20 C147 P1104)

Answer 13

10,000-20,000 IU

Question 14

Dose of intrathecal TIG (H20 C147 P1104)

Answer 14

50-1,500 IU

Question 15

Magnesium sulfate as sedative for tetanus is titrated to: [2] (H20 C147 P1104)

Answer 15

Plasma concentration 2-4 mmol/L, or against disappearance of patellar reflex

Question 16

Primary method of maternal and neonatal tetanus elimination (H20 C147 P1105)

Answer 16

Immunization of pregnant women